| Director, Emerging Policies Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
İsviçre |
People & Organization |
Corporate |
Communications & Public Affairs |
Ara 10, 2024 |
| Country Head, Comms & Patient Advocacy |
Amsterdam |
Hollanda |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 09, 2024 |
| Senior Communications & Patient Advocacy Manager |
Bogota (Pharmaceuticals / GDD / NTO / CTS) |
Kolombiya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 09, 2024 |
| Corporate Communications Director |
London (The Westworks) |
Birleşik Krallık |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 09, 2024 |
| Senior Manager R&D Engagement and Portfolio |
Basel (City) |
İsviçre |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 06, 2024 |
| Senior Manager, R&D Executive Communications and Engagement |
Basel (City) |
İsviçre |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 06, 2024 |
| Corporate Affairs & Patient Relations Manager |
Lima (Pharmaceuticals / GDD / CTS) |
Peru |
International |
Innovative Medicines |
Communications & Public Affairs |
Ara 05, 2024 |
| Therapy Area Communications & Patient Advocacy Manager |
London (The Westworks) |
Birleşik Krallık |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 05, 2024 |
| Director, Portfolio Advocacy LaCan |
INSURGENTES |
Meksika |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
Ara 04, 2024 |
| Director, Policy LaCan |
INSURGENTES |
Meksika |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
Ara 04, 2024 |
| Spécialiste des données et de la connaissance des parties prenantes |
Montreal |
Kanada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 04, 2024 |
| Stakeholder Insights and Data Specialist |
Montreal |
Kanada |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 04, 2024 |
| Senior Manager, Owned Channel Strategy and Intelligence |
Head Office (Japan) (Pharmaceuticals) |
Japonya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 04, 2024 |
| Associate Director, Patient Engagement, Neuroscience and Gene Therapies |
East Hanover |
ABD |
Development |
Innovative Medicines |
Communications & Public Affairs |
Ara 03, 2024 |
| Associate Director, R&D Portfolio and Engagement - Communications |
Cambridge (Massachusetts) |
ABD |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 03, 2024 |
| Manager, Corporate Communications |
Dublin (Country President Office (CPO)) |
İrlanda |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 03, 2024 |
| Executive Director, Public Affairs GCC and MEA Aspiring |
Dubai |
Birl. Arap Emirl. |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
Ara 03, 2024 |
| Therapy Area Communications & Patient Advocacy & Disease Agnostic Lead, Spain |
Barcelona Gran Vía |
İspanya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 03, 2024 |
| Therapy Area Communications & Patient Advocacy Manager |
Barcelona Gran Vía |
İspanya |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 03, 2024 |
| Senior Manager Portfolio Advocacy, Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
İsviçre |
People & Organization |
Corporate |
Communications & Public Affairs |
Ara 02, 2024 |
| Communications Director - Finance |
Basel (City) |
İsviçre |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ara 02, 2024 |
| Senior Manager Policy, Asia Pacific, Middle East and Africa(APMA) |
Basel (City) |
İsviçre |
People & Organization |
Corporate |
Communications & Public Affairs |
Ara 02, 2024 |
| Head, Portfolio Policy |
East Hanover |
ABD |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Ara 02, 2024 |
| Senior Manager, Public Affairs Governance |
Basel (City) |
İsviçre |
CTS |
Corporate |
Communications & Public Affairs |
Kas 29, 2024 |
| Administrative Specialist (EU Public Affairs) |
Brussels |
Belçika |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 29, 2024 |
| Executive Director, Policy and Portfolio Advocacy Region Europe |
Basel (City) |
İsviçre |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 27, 2024 |
| Director, ESG & License to Operate Policy |
Basel (City) |
İsviçre |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 27, 2024 |
| Director, Policy PA Region Europe |
Basel (City) |
İsviçre |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 27, 2024 |
| Director, Portfolio Advocacy Region Europe |
Basel (City) |
İsviçre |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 27, 2024 |
| Executive Director, Public Affairs Strategy |
Basel (City) |
İsviçre |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 26, 2024 |
| Executive Director, Public Affairs (SERCE Czech Republic, Hungary, Poland, Russia, ECC) |
Basel (City) |
İsviçre |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 26, 2024 |
| Executive Director, Public Affairs WEC |
Basel (City) |
İsviçre |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 26, 2024 |
| Manager, US Reputation & Corporate Storytelling |
East Hanover |
ABD |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 26, 2024 |
| Lead - Government Affairs |
Delhi (Office) |
Hindistan |
International |
Innovative Medicines |
Communications & Public Affairs |
Kas 26, 2024 |
| Director, EU Public Affairs |
Brussels |
Belçika |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 25, 2024 |
| Communication & Patient Advocacy Manager (f/m/d) |
Vienna |
Avusturya |
International |
CTS |
Communications & Public Affairs |
Kas 22, 2024 |
| Vice President of European Public Affairs |
Brussels |
Belçika |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Kas 14, 2024 |
| Communications & Patient Advocacy Sr. Specialist (1 yr contract) |
Seoul |
Güney Kore |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Kas 13, 2024 |
| Director, Issue Advocacy & Portfolio Strategy |
Washington, DC |
ABD |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 11, 2024 |
| Associate Director, Issue Advocacy & Strategic Alliances |
Washington, DC |
ABD |
Corporate Affairs |
Corporate |
Communications & Public Affairs |
Kas 11, 2024 |
| Government Affairs Manager |
Moscow (City) |
Rusya Fede. |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
Eki 22, 2024 |
| Public Affairs Manager |
Ankara Gimat |
Türkiye |
International |
Innovative Medicines |
Communications & Public Affairs |
Eyl 13, 2024 |
| Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Almanya |
International |
Innovative Medicines |
Communications & Public Affairs |
Tem 09, 2024 |